David Z.I. Cherney
- Endocrinology, Diabetes and Metabolism top 0.02%
- Surgery top 0.2%
- Nephrology top 0.05%
- Molecular Biology top 2%
- Cardiology and Cardiovascular Medicine top 0.5%
- Co-authors
- Bruce A. PerkinsHiddo J.L. HeerspinkYuliya LytvynPetter BjornstadVesta LaiMaximilian von EynattenChristopher P. CannonMansoor Husain
- Topics
- Diabetes Treatment and Management (181 papers)Chronic Kidney Disease and Diabetes (82 papers)Pancreatic function and diabetes (81 papers)
- Partner nations
- CanadaUnited StatesNetherlands
In The Last Decade
David Z.I. Cherney
314 papers receiving 14.6k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Endocrinology, Diabetes and Metabolism 10.7k
- Surgery 4.9k
- Nephrology 3.8k
- Molecular Biology 3.6k
- Cardiology and Cardiovascular Medicine 2.9k
Countries citing papers authored by David Z.I. Cherney
This map shows the geographic impact of David Z.I. Cherney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Z.I. Cherney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Z.I. Cherney more than expected).
Fields of papers citing papers by David Z.I. Cherney
This network shows the impact of papers produced by David Z.I. Cherney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Z.I. Cherney. The network helps show where David Z.I. Cherney may publish in the future.
Co-authorship network of co-authors of David Z.I. Cherney
This figure shows the co-authorship network connecting the top 25 collaborators of David Z.I. Cherney. A scholar is included among the top collaborators of David Z.I. Cherney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Z.I. Cherney. David Z.I. Cherney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 63 | |
| 10 | 17 | |
| 11 | 5 | |
| 12 | 41 | |
| 13 | 42 | |
| 14 | 4 | |
| 15 | 1 | |
| 16 | 14 | |
| 17 | Sotagliflozin in Patients with Diabetes and Chronic Kidney Diseasebreakdown → | 789 |
| 18 | 175 | |
| 19 | 19 | |
| 20 | Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitusbreakdown → | 976 |
About David Z.I. Cherney
David Z.I. Cherney is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 331 papers that have together received 14.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (181 papers), Chronic Kidney Disease and Diabetes (82 papers) and Pancreatic function and diabetes (81 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (10.7k citations), Nephrology (3.8k citations) and Cardiology and Cardiovascular Medicine (2.9k citations). David Z.I. Cherney has collaborated with scholars based in Canada, United States and Netherlands. Frequent co-authors include Bruce A. Perkins, Hiddo J.L. Heerspink, Yuliya Lytvyn, Petter Bjornstad, Vesta Lai, Maximilian von Eynatten, Christopher P. Cannon, Mansoor Husain, Darren K. McGuire and David Fitchett. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.